← Open Payments lookup

NNEKA EZUNAGU: Open Payments

NPI 1902230253 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$856 in 39 payments from 9 companies in 2025. Trend: 2023 $1,187 · 2024 $1,084 · 2025 $856

Food & beverage: $856
CompanyPaymentsAmount
ABBVIE INC.20$313
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$169
Otsuka America Pharmaceutical, Inc.4$109
Alkermes, Inc.3$73
E.R. Squibb & Sons, L.L.C.3$69
Janssen Pharmaceuticals, Inc2$56
Luye Pharma (USA) Ltd.1$25
Vanda Pharmaceuticals Inc.1$23
Axsome Therapeutics, Inc.1$18

Products named: VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, COBENFY, INVEGA SUSTENNA, REXULTI, ERZOFRI EXTENDED-RELEASE.

Industry payments across MD — which companies pay providers there.